Alamar Biosciences (ALMR) vs Avantor (AVTR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Avantor is the larger company by market cap ($10.41 billion vs $1.80 billion), about 5.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | AVTR |
|---|---|---|
| Share price | $25.91 | $15.39 |
| Market cap | $1.80B | $10.41B |
| 1-day change | -6.70% | +0.26% |
| YTD return | — | +34.29% |
| 1-year return | — | +11.93% |
| 5-year return | — | -59.87% |
| Forward P/E | — | 17.54 |
| EPS (TTM) | $-1.20 | $-0.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $6.55B |
| Revenue growth (YoY) | — | -3.41% |
| Net income (latest FY) | — | $-530.20M |
| Gross margin | — | 32.65% |
| Operating margin | — | -3.76% |
| Net margin | — | -8.09% |
| 52-week high | $39.61 | $16.38 |
| 52-week low | $18.85 | $7.27 |
| Distance from 52-week high | -34.59% | -6.02% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +36.63% | -3.96% |
| Average volume | 411.15K | 9.43M |
| Shares outstanding | 69.39M | 676.36M |
| Employees | 286 | 13,500 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Avantor is about 5.8 times larger than Alamar Biosciences by market value ($10.41B vs $1.80B).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Avantor
AVTR stock →Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Industrials · Biotechnology: Laboratory Analytical Instruments · 13,500 employees
ALMR vs AVTR FAQ
Which is bigger, Alamar Biosciences or Avantor?
Avantor (AVTR) is larger, with a market capitalization of $10.41B compared with $1.80B for Alamar Biosciences (ALMR).
Are Alamar Biosciences and Avantor in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.